You are here: Industry Insights > Centogene

News List

Centogene Appoints Miguel Coego Rios EVP Finance & Legal and Interim CFO contractpharma
February 08, 2022
Réne Just, the current CFO, will resign at the end of March.
Centogene Appoints Dr. Michael Motz as CCO contractpharma
May 19, 2021
Motz is an entrepreneur and executive with over 25 years of industry experience.
Centogene Receives EUA for SARS-CoV-2 RT-PCR Assay americanpharmaceuticalreview
October 23, 2020
Centogene announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for CentoSure, the company's latest SARS-CoV-2 RT-PCR test.
Centogene, Molecular Health Partner to Transform Biomedical Research contractpharma
July 29, 2020
Aims to foster novel precision medicine environment to accelerate, de-risk, and improve the development of new orphan drugs combining big data and AI.
Centogene Appoints Interim CBO contractpharma
May 18, 2020
Sun Kim succeeds Oved Amitay, who will be stepping down and leaving the Company.
CENTOGENE Announces Global Expansion of COVID-19 Testing americanpharmaceuticalreview
May 06, 2020
CENTOGENE will expand its testing efforts for the novel coronavirus, or COVID-19. The Company was previously testing in Germany’s Mecklenburg-Western Pomerania region.
Centogene Opening Lab to Increase COVID-19 Testing contractpharma
April 16, 2020
Acquiring former laboratory facilities and equipment of Provecs Medical GmbH in Hamburg, Germany.
CENTOGENE Announces Commencement of Testing for COVID-19 americanpharmaceuticalreview
March 23, 2020
CENTOGENE will commence testing for the novel coronavirus, or COVID-19. Testing for the virus is part of the Company’s initiative to help local, national ...
CENTOGENE Appoints AI Director contractpharma
April 19, 2019
Dr. Carsten Ullrich, Ph.D. has been appointed director of Artificial Intelligence to lead the company's efforts in using AI to discover new insights, accelerate biomarker development, and drive solutions for pharmaceutical companies.
CENTOGENE Announces Agreement with Aldeyra Therapeutics for the Advancement of Novel Therapeutics for Patients with Sjögren-Larsson Syndrome firstwordpharma
May 30, 2018
ROSTOCK, Germany--(BUSINESS WIRE)-- CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced that it has entered into an agreement with Aldeyra Therapeutics Inc.,

Previous page 1 2 Next page